Approvals/TGA/CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use

Approved

STANDARD

CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fabd94d1fc78b7fb
Product Name: CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use
Artg Id: 204955
Artg Name: CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2013-01-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

fabd94d1fc78b7fb

Type

Standard